175 Results

People

  1. Saltz
    Saltz
  2. Schwartz
    Schwartz
  3. Ilson
    Ilson
  4. Kelsen
    Kelsen
  5. Kemeny
    Kemeny
  6. O'Reilly
    O'Reilly
  7. Gonen
    Gonen
  8. Modi
    Modi
  9. Jarnagin
    Jarnagin
  10. Bertino
    Bertino

Groups

  1. Department of Medicine (109)
  2. Solid Tumor Oncology Division (102)
  3. Gastrointestinal Oncology Service (73)
  4. Center for Pancreatic Cancer Research (42)
  5. Epidemiology and Biostatistics (21)
  6. Biostatistics Service (20)
  7. Surgery (18)
  8. Breast Medicine Service (15)
  9. GSK Faculty (15)
  10. Population Sciences Research Program (14)
  1. "camptothecin"
Formats
  1. Journal Article (163)
  2. Conference Paper (4)
  3. Review (4)
  4. Correspondence (2)
  5. Editorial (1)
  6. Meeting Abstract (1)
Groups
  1. Department of Medicine (109)
  2. Solid Tumor Oncology Division (102)
  3. Gastrointestinal Oncology Service (73)
  4. Center for Pancreatic Cancer Research (42)
  5. Epidemiology and Biostatistics (21)
  6. Biostatistics Service (20)

More Groups

People
  1. Leonard Saltz (39)
  2. Gary Schwartz (23)
  3. Nancy Kemeny (23)
  4. David Ilson (22)
  5. David Kelsen (20)
  6. Eileen O'Reilly (15)

More People

Years
  1. 2025 (3)
  2. 2024 (11)
  3. 2022 (6)
  4. 2021 (2)
  5. 2020 (1)
  6. 2019 (1)

More Years

Publications
  1. Journal of Clinical Oncology (17)
  2. Clinical Cancer Research (14)
  3. Oncology (Norwalk) (12)
  4. Cancer Research (10)
  5. Annals of Oncology (8)
  6. Cancer (8)

More Publications

Publishers
  1. American Association for Cancer Research (26)
  2. Oxford University Press (19)
  3. American Society of Clinical Oncology (17)
  4. Elsevier Inc. (14)
  5. Springer (14)
  6. C M P Medica LLC * The Oncology Group (12)

More Publishers

Results (175)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Camptothecin analogs (irinotecan or topotecan) plus high-dose cyclophosphamide as preparative regimens for antibody-based immunotherapy in resistant neuroblastoma
    Journal Article

    Kushner, B. H.; Kramer, K.; Modak, S.; Cheung, N. K. V.
    Clinical Cancer Research (2004)

    Fulltext@MSK | Save
  • Randomized phase II trial of gemcitabine plus irinotecan or docetaxel in stage IIIB or stage IV NSCLC
    Journal Article

    Rocha Lima, C. M. S.; Rizvi, N. A.; Zhang, C.; Herndon, J. E.; Crawford, J.; Govindan, R.; King, G. W.; Green, M. R.
    Annals of Oncology (2004)

    Fulltext@MSK | Save
  • Extent of hepatic resection does not correlate with toxicity following adjuvant chemotherapy
    Journal Article

    Carlo, W.; Hummer, A. J.; Schwartz, L.; Sullivan, D.; Gonen, M.; Jarnagin, W.; Fong, Y.; Kemeny, N.
    Journal of Surgical Oncology (2004)

    Fulltext@MSK | Save
  • Potentiation of cytotoxicity of topoisomerase I poison by concurrent and sequential treatment with the checkpoint inhibitor UCN-01 involves disparate mechanisms resulting in either p53-independent clonogenic suppression or p53-dependent mitotic catastrophe
    Journal Article

    Tse, A. N.; Schwartz, G. K.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Phase II trial of weekly irinotecan/cisplatin in advanced esophageal cancer
    Journal Article

    Ilson, D. H.
    Oncology (Norwalk) (2004)

    Fulltext@MSK | Save
  • The camptothecins
    Journal Article

    Pizzolato, J.; Saltz, L. B.
    Lancet (2003)

    Fulltext@MSK | Save
  • Oesophageal cancer: New developments in systemic therapy
    Journal Article

    Ilson, D. H.
    Cancer Treatment Reviews (2003)

    Fulltext@MSK | Save
  • Combined modality therapy in esophageal cancer: The Memorial experience
    Journal Article

    Anderson, S. E.; Minsky, B. D.; Bains, M.; Kelsen, D. P.; Ilson, D. H.
    Seminars in Surgical Oncology (2003)

    Fulltext@MSK | Save
  • Activation of a camptothecin prodrug by specific carboxylesterases as predicted by quantitative structure-activity relationship and molecular docking studies
    Journal Article

    Yoon, K. J. P.; Krull, E. J.; Morton, C. L.; Bornmann, W. G.; Lee, R. E.; Potter, P. M.; Danks, M. K.
    Molecular Cancer Therapeutics (2003)

    Fulltext@MSK | Save
  • Irinotecan (Campto®) in the treatment of pancreatic cancer
    Journal Article

    Pizzolato, J.; Saltz, L. B.
    Expert Review of Anticancer Therapy (2003)

    Fulltext@MSK | Save